NVCR Q4 2025 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$174M+8.1% YoY

Gross Profit

$132M75.8% margin

Operating Income

-$40M-23.2% margin

Net Income

-$24M-14.1% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$23M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$804M

Total Liabilities

$464M

Stockholders' Equity

$340M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$174M	$161M	+8.1%
Gross Profit	$132M	$128M	+3.4%
Operating Income	-$40M	-$63M	+36.2%
Net Income	-$24M	-$66M	+62.8%

Geographic Segments

UNITED STATES

$102M45%

International Markets

$68M30%

GERMANY

$21M9%

FRANCE

$20M9%

JAPAN

$10M5%

CHINA

$5M2%